MedTrace Logo

Managed Ventricular Pacing ("MVP") Trial

NCT00281099 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1031

Last updated 2010-08-03

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ICD and the status of congestive heart failure.

Conditions

Interventions

DEVICE

ICD (Implantable Cardioverter Defibrillator)

VVI 40 vs. MVP

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Michael O Sweeney · Brigham and Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States
  • Austria
  • Canada
  • Denmark
  • France
  • Germany
  • Israel
  • Italy
  • Norway
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00281099 on ClinicalTrials.gov